Syndicate Bio
PrivateLast Round
VC Round
May 20, 2025
Total Funding Raised
$145,000
Momentum Score
75 /100
Company Overview
Syndicate Bio is a biotechnology company that operates as a platform for genomics and precision medicine initiatives, with a primary focus on Africa. The company aims to build diverse human health datasets and applies artificial intelligence and machine learning (AI/ML) to facilitate new discoveries and promote inclusive healthcare globally. Syndicate Bio collaborates with governments, pharmaceutical companies, academic institutions, and other stakeholders to enhance local precision medicine and generate datasets for drug discovery and development. The company provides genomic solutions, such as cancer sequencing tests, and operates a personal health portal called "Direct by Syndicate Bio". It was founded in 2023 by Dr. Abasi Ene-Obong, the former CEO of 54gene, along with co-founders Dr. Jumi Popoola and Estelle Dogbo. Syndicate Bio has offices in Newark, Delaware, and Lagos, Nigeria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Usage-Based SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Syndicate Bio Comps
Public and private peers based on sector, stage, and business model.
Syndicate Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 20, 2025 | ||||
| Seed | Sep 13, 2024 |
Syndicate Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | VC Round, Seed |
| Belal Badat Ventures | Seed |
| Nubia Capital | Seed, VC Round |
| StoryHouse Ventures | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors grew 99% MoM, reaching 3.9K.
- Oct 7, 2025
Launched Direct by Syndicate Bio, a genetic testing service for Africa.
Syndicate Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Syndicate Bio's valuation, stock price, and market status.
